Ignite Creation Date:
2024-07-17 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497491
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-05
Brief Title:
An Efficacy and Safety Study of GNR-086 canakinumab Biosimilar and Ilaris in Patients with Adult-onset Still39s Disease
Sponsor:
AO GENERIUM
Organization:
AO GENERIUM
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stills Disease Adult Onset |
Keywords:
| Name | View |
|---|---|
| canakinumab | View |
| humanized monoclonal antibodies | View |
| safety | View |
| Stills disease adult onset | View |
| equivalence | View |
| biosimilar | View |
| American College of Rheumatology ACR | View |
| DAS28 | View |
| disease-modifying anti-rheumatic drugs DMARDs | View |
| European League Against Rheumatism EULAR | View |
| immunogenicity | View |